YahooAugust 13, 2026 at 9:05 AM NY22 days ago
Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover
Wave Life Sciences has lost nearly 70% of its value this year, yet its RNA platform spans obesity, rare liver disease, and genetic disorders in ways that could make it irresistible to the right buyer. The question is which pharma giant moves first.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo
Companies in This Story
Related Stories
Sodexo : Monthly disclosure on share capital and voting rights August 31, 2026
Yahoo1 hour ago
ANF vs. TPR: Which Stock Is the Better Value Option?
Yahoo1 hour ago
Anthropic's IPO Push Just Got a $15 Billion Backstop
Yahoo1 hour ago
Why Is Circle Internet Group, Inc. (CRCL) Up 63.1% Since Last Earnings Report?
Yahoo1 hour ago
Radian (RDN) Up 1.5% Since Last Earnings Report: Can It Continue?
Yahoo1 hour ago